REGN
Regeneron Pharmaceuticals, Inc.
- Total liabilities, 2025
- $9.3B
- YoY, 2025
- +10.7%
- 5-year CAGR
- +8.7%
- 10-year CAGR
- +16.9%
Total liabilities
Total liabilities by fiscal year
| Period | Total liabilities | YoY |
|---|---|---|
| 2025 | $9.3B | +10.7% |
| 2024 | $8.4B | +18.3% |
| 2023 | $7.1B | +8.5% |
| 2022 | $6.6B | −1.7% |
| 2021 | $6.7B | +8.6% |
| 2020 | $6.1B | +65.2% |
| 2019 | $3.7B | +24.8% |
| 2018 | $3.0B | +13.6% |
| 2017 | $2.6B | +3.8% |
| 2016 | $2.5B | +29.2% |
| 2015 | $2.0B | +51.8% |
| 2014 | $1.3B | +28.9% |
| 2013 | $999M | +19.6% |
| 2012 | $835M | −0.3% |
| 2011 | $838M | +49.2% |
| 2010 | $562M | +63.1% |
| 2009 | $344M | — |